Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ · Healthcare
Harmony Biosciences Holdings, Inc. EPS 2020–2025
Harmony Biosciences Holdings, Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Harmony Biosciences Holdings, Inc. eps for the quarter ending March 31, 2026 was $0.55, a 29.49% decrease year-over-year.
- Harmony Biosciences Holdings, Inc. annual eps for 2025 was $2.71, a 7.97% increase from 2024.
- Harmony Biosciences Holdings, Inc. annual eps for 2024 was $2.51, a 17.84% increase from 2023.
- Harmony Biosciences Holdings, Inc. annual eps for 2023 was $2.13, a 28.28% decrease from 2022.
- Harmony Biosciences Holdings, Inc. annual eps for 2022 was $2.97.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Harmony Biosciences Holdings, Inc. EPS — FAQ
Harmony Biosciences Holdings, Inc. (HRMY) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Harmony Biosciences Holdings, Inc.'s eps?
Harmony Biosciences Holdings, Inc. (HRMY) reported eps of $2.71 for fiscal 2025.
Where can I see HRMY's eps history?
The chart and table above show Harmony Biosciences Holdings, Inc.'s eps by year and by quarter, including the growth rate.